当前位置: 首页 > 期刊 > 《中国药房》 > 20196
编号:13559864
中草药黄酮类化合物治疗肝纤维化分子信号通路的研究进展(5)
http://www.100md.com 2019年3月15日 《中国药房》 20196
     [41] ZOU CG,GAO SY,ZHAO YS,et al. Homocysteine enhances cell proliferation in hepatic myofibroblastic stellate cells[J]. J Mol Med,2009,87(1):75-84.

    [42] CANTLEY LC. The phosphoinositide 3-kinase pathway[J]. Science,2002,296(5573):1655-1657.

    [43] CORPECHOT C,BARBU V,WENDUM D,et al. Hypoxia-induced VEGF and collagen Ⅰ expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis[J]. Hepatology,2002,35(5):1010-1021.

    [44] 潘澎.芪術颗粒对肝纤维化形成过程中PI3K/Akt信号转导通路的影响[D].北京:北京中医药大学,2013.

    [45] LIN X,BAI F,NIE J,et al. Didymin alleviates hepatic fibrosis through inhibiting ERK and PI3K/Akt pathways via regulation of raf kinase inhibitor protein[J]. Chem Biol Interact,2016,40(6):1422.

    [46] 李晚霞.橙皮素衍生物对四氯化碳诱导的大鼠肝纤维化的治疗作用及部分机制研究[D].合肥:安徽医科大学,2017.

    [47] GUO C,XU L,HE Q,et al. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway[J]. Food Chem Toxicol,2013,56(19):436-442.

    (收稿日期:2018-08-06 修回日期:2018-12-21)

    (编辑:余庆华), 百拇医药(韦淇元 唐秀能 黄仁彬)
上一页1 2 3 4 5